PMA device
Intera 3000 Hepatic Artery Infusion Pump
Intera Oncology · Pump, Infusion, Implanted, Programmable (LKK, Class III) · First FDA decision Sep 3, 2024, newest Sep 3, 2024Chronic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
4
Naming "3000 Hepatic Artery"
MAUDE reports
12
Brand "3000 Hepatic Artery", since 2015
PubMed studies
0
Mentioning "3000 Hepatic Artery"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Intera 3000 Hepatic Artery Infusion Pump
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Intera 3000 Hepatic Artery Infusion PumpPMA supplement
P890055-S085 · Decided Sep 3, 2024 · 180 days after receipt · Normal 180 Day Track No User Fee
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "3000 Hepatic Artery", any status and sponsor, newest update first.
National Cancer Institute (NCI)NIH
NCT05286814 · 70 participants (planned) · Start Oct 24, 2022 · Primary completion Dec 31, 2027
Device: Intera 3000 Hepatic Artery Infusion Pump (HAIP) · For: Metastatic Colorectal Cancer (Mcrc); Intrahepatic Cholangiocarcinoma (Icc); Intrahepatic Bile Duct Cancer and 10 more
Sites: Bethesda, Maryland
National Cancer Institute (NCI)NIH
NCT03366155 · 24 participants · Start Jun 24, 2019 · Primary completion Nov 13, 2025
Device: Codman 3000 constant flow pump catheter; Medtronic SynchroMed II Pump · For: Colorectal Cancer; Liver Metastases; Colorectal Adenocarcinoma and 2 more
Sites: Bethesda, Maryland
Michael J Cavnar, MDAcademic, hospital or other
NCT07201519 · 80 participants (planned) · Start Jan 23, 2026 · Primary completion Feb 2028
Device: Hepatic Artery Infusion Pump (HAIP) · For: Colorectal Cancer Metastatic; Intrahepatic Cholangiocarcinoma
Sites: Lexington, Kentucky
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "3000 Hepatic Artery", and for the whole product code for context.
This brand
12 reports: 12 malfunction, 0 injury, 0 death
Whole product code LKK
71,356 reports: 25,333 malfunction, 45,674 injury, 326 death
Newest reports for this brand
3015537318-2026-00002 · Received Jan 13, 2026 · Event dated Dec 17, 2025
Device type: Non-Coring (Huber) Needle (PTI)
Device problem as coded: Fluid/Blood Leak
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3015537318-2025-00107 · Received Nov 18, 2025 · Event dated Oct 21, 2025
Device type: Non-Coring (Huber) Needle (PTI)
Device problem as coded: Device Contamination with Chemical or Other Material
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3015537318-2025-00087 · Received Sep 12, 2025 · Event dated Aug 18, 2025
Device type: Non-Coring (Huber) Needle (PTI)
Device problem as coded: Fluid/Blood Leak
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Intera Oncology INTERA 3000 Hepatic Artery Infusion Pump, AP-0300H, implantable drug delivery deviceCompleted
Z-2580-2026 · Started May 11, 2026 · Posted by FDA Jun 25, 2026
Reason given: There is the potential for leakage along the drug pathway from the pump through the end of the catheter.
Cause as FDA categorized it: Process control · Device type: Pump, Infusion, Implanted, Programmable (LKK)
- INTERA 3000 Hepatic Artery Infusion Pump, 30 mL, Sterile, Rx Only. implantable infusion pump.Terminated
Z-1522-2022 · Started Jul 10, 2022 · Posted by FDA Aug 22, 2022
Reason given: Higher than expected flow rate.
Cause as FDA categorized it: Process design · Device type: Pump, Infusion, Implanted, Programmable (LKK)
Z-1571-2014 · Started Nov 10, 2015 · Posted by FDA May 9, 2014
Reason given: A small number of specific pumps may trigger a low battery alarm at the beginning of the implanted life.
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Implanted, Programmable (LKK)
12 more recall records with a free account
Published research
The most relevant PubMed records for "3000 Hepatic Artery"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LKK.
- SynchroMed Infusion System, Ascenda Intrathecal CathetersMedtronic, Inc. · PMA 2026
- Prometra Programmable Infusion Pump SystemInfusyn Therapeutics, LLC · PMA 2025
- Synchromed II Pump RemediationMedtronic, Inc. · PMA 2017
- Implantable System for RemodulinMedtronic, Inc. · PMA 2021
- Medstream Programmable Infusion SystemIntera Oncology · PMA 2014
- IsoMed Infusion SystemMedtronic, Inc. · PMA 2023
- INFUSAID Implantable Infusion Pump and AccessoriesIntera Oncology · PMA 2020
- Medtronic(R) Synchromed(Tm) Pump & Infusion SystemMedtronic, Inc. · PMA 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.